Evaluation of analgesic efficacy of ESP block versus TPV block in patients undergoing tissue expander breast reconstruction

Randomized, single-blind,parallel clinical trial on analgesic efficacy of ESP block versus TPV block in patients undergoing tissue expander breast reconstruction - trial on analgesic efficacy of ESP block versus TPV block in patients undergoing tissue expander breast reconstruction

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000039700

Enrollment

Registered

2020-03-04

Start date

2020-03-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

The administration of the erector spinae plane block for the postoperative analgesia in the patients scheduled for breast reconstruction surgery with tissue expander The administration of the thoracic

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: ASA physical status classification I-II

Exclusion criteria

Exclusion criteria: Patients who receive regurally analgesics within preoperative one month Patients with dementia Patients with thrombocytopenia or coagulopathy Patients undergoing antiplatelet or anticogulant therapy Patients with allergy to ropivacaine Patients who are pregnant or nursing

Design outcomes

Primary

Measure	Time frame
postoperative visual analogue scale	—

Secondary

Measure	Time frame
complication	—

Countries

Japan

Contacts

Public ContactKyoko Oshita

Hiroshima University Hospital anesthesiology

oshitak@hiroshima-u.ac.jp0822575267

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026